Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Veterinary Pathology|October 5, 2020
Naturally Acquired Mouse Kidney Parvovirus Infection Produces a Persistent Interstitial Nephritis in Immunocompetent Laboratory MiceElijah F Edmondson, Wang-Ting Hsieh, Josh A Kramer, et al.
Biomedical Reports|February 10, 2025
Role of dasatinib in the management of lung cancer: A meta-analysis of clinical trialsBerun A Abdalla, Rebaz M Ali, Fahmi H Kakamad, et al.
International Journal of Surgery Case Reports|February 16, 2021
Aneurysm of anomalous splenic artery arising from a splenomesenteric trunk: Review of the literature with a report of a new caseFahmi H Kakamad, Zuhair D Hammood, Abdulwahid M Salih, et al.
Cancer Discovery|January 26, 2021
TNIK Is a Therapeutic Target in Lung Squamous Cell Carcinoma and Regulates FAK Activation through MerlinPedro Torres-Ayuso, Elvira An, Katherine M Nyswaner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2023
Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma ModelsGrace B McKay-Corkum, Victor J Collins, Choh Yeung, et al.
Science Signaling|February 11, 2025
Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumorsAmy L Funk, Meghri Katerji, Marwa Afifi, et al.
Molecular Cancer Research : MCR|May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseMasaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Targeting GOF p53 and c-MYC through LZK Inhibition or Degradation Suppresses Head and Neck Tumor GrowthAmy L Funk, Meghri Katerji, Marwa Afifi, et al.
Molecular Cancer Therapeutics|October 14, 2024
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82Susana S Najera, Christopher J Ricketts, Laura S Schmidt, et al.
Pageof 6